Selasa, 31 Oktober 2017

FDA approves new treatment for adults with mantle cell lymphoma - FDA.gov


New York Daily News

FDA approves new treatment for adults with mantle cell lymphoma
FDA.gov
The U.S. Food and Drug Administration today granted accelerated approval to Calquence (acalabrutinib) for the treatment of adults with mantle cell lymphoma who have received at least one prior therapy. “Mantle cell lymphoma is a particularly aggressive ...
AstraZeneca wins US approval for lymphoma drugABC News
FDA Approves Acalabrutinib (Calquence) for Mantle Cell LymphomaMedscape
Mantle Cell Lymphoma Drug Gets FDA OKPharmacy Times
HealthDay -MedPage Today -UPI.com -Cancer Therapy Advisor
all 30 news articles »


from Health - Google News http://ift.tt/2zWcTlc


EmoticonEmoticon